SPL 0.00% 10.5¢ starpharma holdings limited

Ann: VivaGel BV NDA advances to next stage of FDA review, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 587 Posts.
    lightbulb Created with Sketch. 79
    not the way I read it. it is 6 months from today.

    April 30 announcement: it stated "approximately 6-8 months from the completed submission" . Submission was completed April 30, so Nov or Dec for the NDA.

    today's announcement : it states "target review period of approximately 6 months from acceptance" acceptance was today, so January 9th 2019..

    I was hoping to see the NDA approval this calendar year, but likely January 2019 based on this. Or maybe this is the start of SPL being more conservative with their timeline estimates.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $43.90M
Open High Low Value Volume
10.5¢ 11.5¢ 10.0¢ $110.6K 1.006M

Buyers (Bids)

No. Vol. Price($)
1 83046 10.5¢
 

Sellers (Offers)

Price($) Vol. No.
11.0¢ 30000 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.